Skip to content

Biotalys

Active
Public limited companyfounded 201313 years activeBuchtenstraat 11, 9051 Gent, BelgiumKBO/BCE: BE 0508.931.185
Summary

The annual accounts of Biotalys for fiscal year 2025 show a net loss of 93% of total assets and of 61% of the equity at the start of that year. The 2025 annual accounts show equity of €9.9m and a net result of -€15.1m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 56% of 239 sector peers (NACE 72, fiscal year 2025). The company has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.6% (low).

Overview

Activity
Research and development on biotechnology
NACE 72101Other research and development on natural sciences NACE 72109
#8 employer in East Flanders, Research and development sector1 site
Size
€16.3mtotal assets 2025
Staff
58.2 FTE
Equity
€9.9m
Loss
-€15.1m
Standalone figures, without subsidiaries
Financial health
54 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.6%
Structure
Largest shareholder
ACKERMANS & VAN HAAREN · 15.43%
Board
9 members
Holdings
1
  • Simon E MoroneyChair
  • Gimax Consulting BVDaily manager · permanent representative Luc Van fraeyenhoven
Auditor: DELOITTE Bedrijfsrevisoren BVAccounts 43 days early
Why 54Capped at 59: a net loss of at least half of total assets or of the equity at the start of the financial year- Loss of €15.1m, the second in a row (FY 2025)- Liquidity: current ratio 4.16, cash €99,134, halved+ Figures for FY 2025 (filed 18-06-2026)+ Equity €9.9m (60.6% of total assets)Show the evidence

Checked score

Score 2025
54 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 36% of its sector peers (NACE 72, medium-sized)
A net loss of at least half of total assets or of the equity at the start of the financial year caps the score at 59. Every signal that weighs is under Signals.
Financial strength · tick = 2024
Weak
Solvency 86-14
equity 60.6% of total assets
Liquidity 44-19
short-term debt 20.4% · cash 0.6%
Profitability 0=
return on assets -92.8%
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (47 companies)
Last 24 months 11-2024: 0.2% 12-2024: 0.3%▲ +0.1 percentage points vs 11-2024 01-2025: 0.4%▲ +0.1 percentage points vs 12-2024 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.3%▼ -0.1 percentage points vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.2%▼ -0.1 percentage points vs 05-2025lowest value 07-2025: 0.2%● unchanged vs 06-2025lowest value 08-2025: 0.2%● unchanged vs 07-2025lowest value 09-2025: 0.2%● unchanged vs 08-2025lowest value 10-2025: 0.2%● unchanged vs 09-2025lowest value 11-2025: 0.2%● unchanged vs 10-2025lowest value 12-2025: 0.2%● unchanged vs 11-2025lowest value 01-2026: 0.2%● unchanged vs 12-2025lowest value 02-2026: 0.2%● unchanged vs 01-2026lowest value 03-2026: 0.2%● unchanged vs 02-2026lowest value 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.6%▲ +0.4 percentage points vs 06-2026highest value 08-2026: 0.6%● unchanged vs 07-2026highest value 09-2026: 0.6%● unchanged vs 08-2026highest value 10-2026: 0.6%● unchanged vs 09-2026highest value
Credit up to €500,000 at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity ample (current ratio 4.16 against 8.07 in 2024; short-term debt: 20.4% and cash: 0.6% of total assets), and 39.4% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, medium-sized): better than 64% on solvency, 49% on liquidity, 11% on profitability and 19% on growth.

The bankruptcy probability was computed on 07-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals.
−lowers risk+raises risk○neutral
raises risk · Loss of €15.1m, the second in a row (FY 2025)
NBB · annual accounts
raises risk · Liquidity: current ratio 4.16, cash €99,134, halved
NBB · annual accounts
lowers risk · Figures for FY 2025 (filed 18-06-2026)
NBB · annual accounts
lowers risk · Equity €9.9m (60.6% of total assets)
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
18192021222425
2018 to 2025 · latest year -€15.1m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-06-2026, 43 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
43 days early
2024
99 days early
2023
75 days early
2022
80 days early
2021
94 days early
2020
103 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 82 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 12 May (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
08-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Resignations: Johan Cardoen, Patrick Van Beneden…Appointment: Boutton Consulting BV (chief…
  2. Annual accounts filedfiscal year 2025 · consolidated
  3. Annual accounts filedfiscal year 2025 · full…

Key points

  • Risk: 7 loss-making years in a rowloss fiscal year 2025 -€15.1m View
  • Caution: Among the weakest 5% on net resultsector median €4,111 · 236 companies -€15.1m View
  • Caution: Equity fell in 2025from €24.8m to €9.9m ▼ 60.1% View
  • Board changedlatest change 01-07-2026 · 9 in office 2 joined · 5 left View
  • Flemish supportawarded 2022 - 2025 €1.6m View
  • Positive: Always filed on timeaccounts within the deadline every year 6 years View

By topic

Financials

Fiscal year
2025
Total assets
€16.3m
Loss
-€15.1m
Solvency
60.6%
Total assets▼ 49.6%
Net result
20182025
Go to Financials

Board & ownership

Board
9 members
Largest shareholder
ACKERMANS & VAN HAAREN · 15.43%
Auditor
DELOITTE Bedrijfsrevisoren BV
  • Simon E MoroneyChair
  • Luc Jozef Maria BASSTANIEDirector
  • Patrice Emmanuel SÈLLESDirector
  • Pieter Robrecht BEVERNAGEDirector
  • HELDT Markus FranzDirector

and 4 other directors

Go to Board & ownership

Timeline

Events
74
Since
2013
Next accounts
by 31-07-2027
  1. 12-06-2026Capital & shares · Statutes amendment
  2. 05-05-2026Resignations: Laura Meyer (director) and Kevin Helash…
  3. 28-10-2025Capital & shares · Statutes amendment
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Research and development on biotechnologyNACE 72101
Founded
04-01-2013
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
3
Purpose
De exploitatie van biologische en chemische producten, processen en technologieën voor de…
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.